Article, Pharmaceutical

Where contamination risks actually sit in practice

26 Jun 2026

This article explores how contamination risks materialize across Aptar Pharma Injectables’ manufacturing operations, beyond formal systems. Through a “Point Zero” approach, it examines how legacy equipment, material flows, and operational constraints shape risk in practice, and how mapping these realities supports more structured Contamination Control Strategy (CCS) implementation. 

By: Nicolas Voisin (Global Quality Senior Director, Aptar Pharma Injectables)
Share
26 Jun 2026
An operator in cleanroom attire is inspecting a component under a magnifying lamp in a pharmaceutical production environment

Speaking about operational realities openly makes the CCS discussion more useful and more relevant for people dealing with comparable conditions across the industry. 

 

In our first blog, we shared how Contamination Control Strategy (CCS) became a concrete operational topic for Aptar Pharma Injectables. It was not the beginning of our contamination-control journey. The organization already had a long history in this area, with milestones ranging from Ready-To-Sterilize components in the 1970s to Ultra Clean 6, sterile plungers and stoppers and the progressive deployment of classified environments around critical production steps. 

That history matters because Aptar Pharma had already been pioneering on several topics that are now central to CCS thinking. The new production concept introduced in 2009, for example, was already very close in spirit to what CCS now formalizes: reducing human intervention through automation, limiting intermediate storage, controlling environments more consistently from molding to primary packaging and using real-time process monitoring to support a higher level of microbiological and particulate cleanliness. 

Building on this legacy, CCS gave us an opportunity to step back, connect these existing elements more explicitly and look again at our plants with a broader and more structured view. 

As manufacturers implement EU GMP Annex 1 requirements, responsibility for contamination control extends across the supply chain. Suppliers are increasingly expected to demonstrate how their own operations contribute to product quality, providing greater confidence through robust processes, controls and supporting data. 

That meant walking the full environment, zone by zone and department by department, from incoming materials to shipping, with one simple question in mind: where can contamination enter, move, or remain undetected? 

We called this exercise Point Zero. It was a way of returning to the field with the benefit of that history, but without letting past achievements limit what we were prepared to see. 

The name was simple on purpose. Before refining systems, updating documents or launching corrective actions, we wanted to start with what was physically there - the environment as it operates day after day. 

 

Looking at operations with a different lens 

What emerged was familiar. That was precisely the point. 

Across industrial environments, including our own, contamination control is shaped by a combination of solid systems and long-standing operational realities. Legacy equipment. Material flows that have changed over time as the plant expanded. Packaging practices that remain in place because they are practical, established, or not always easy to change quickly. 

Individually, none of these points was exceptional. Taken together, they gave a clearer view of contamination risks and what it takes to manage them consistently. 

That was one of the most useful outcomes of Point Zero. It grounded the discussion. It brought contamination control back to the reality of industrial operations, where risk is often influenced by interfaces, movement, legacy arrangements and everyday decisions. 

 

What we saw in practice 

Some examples were very concrete. We reviewed the continued presence of wood pallets in parts of the industrial environment and launched a dedicated Zero Wood project to progressively remove them from production-related surroundings. That work included scenario evaluation, prioritization of quick wins and discussions with suppliers so that packaging practices could begin changing further upstream. 

We also reviewed the condition and cleanability of parts of our molding equipment fleet. The point was not to single out specific assets, but to better understand how equipment condition, maintenance and cleaning practices affect contamination control over time. This led to a structured renewal plan, together with trials of targeted cleaning solutions for areas that are less accessible in routine operations. 

This kind of work rarely attracts much attention when CCS is discussed in abstract terms. Still, it is exactly where contamination control becomes tangible. 

What Point Zero reinforced for us is that contamination risks are closely linked to how materials and activities move through operations. It is shaped by how materials move, how areas interact, how packaging enters the environment and how legacy systems are reviewed over time. 

This is also not unique to one company. Many manufacturers, suppliers and competitors operate with similar constraints. Speaking about them openly matters because it makes the conversation more useful - and more relevant - for people dealing with comparable realities across the industry. 

 

What this revealed 

A few observations from this phase may be useful beyond our own operations. 

The next step for us was to structure what we saw. Each zone, flow and potential source was mapped and reviewed. That work did not produce one single conclusion. It gave us overall a clearer basis for prioritization and decision-making. 

Contamination risks are often found at interfaces. They tend to sit where materials, people, environments and routines meet. These areas are easy to normalize over time, especially in long-established industrial settings. 

Operational constraints deserve to be addressed directly. They do not need to be overstated and they do not need to be hidden either. They are part of the industrial context in which CCS has to function. 

A site-wide view changes the quality of the discussion. Once operations are looked at end to end, contamination control becomes easier to discuss in practical terms. The conversation moves closer to real choices, clearer priorities and more consistent action. 

For the reader, that is probably the most useful takeaway. CCS gains value when it is connected to the actual conditions in which manufacturing takes place. That includes the highly controlled parts of the process, but also the interfaces, transitions and inherited operating conditions that influence contamination risk in quieter ways. 

 

Looking ahead 

Point Zero gave us a grounded starting point. It helped us build the next steps on something that reflected real operations rather than assumptions. 

In the next article, we will look at another area where contamination control often starts earlier than expected: behaviors, routines and what happens before entering controlled environments.